Literature DB >> 23503785

[Pharmacological treatment of delirium in palliative care patients. A systematic literature review].

K M Perrar1, H Golla, R Voltz.   

Abstract

This systematic literature review aims to collect and analyse relevant clinical trials for the drug treatment of delirium in palliative care. The search was conducted including July 2012 in Medline (from 1966) and Embase (from 1974). The search retrieved 448 studies, of which 3 studies could be included in the analysis. Treatment with the antipsychotic drug haloperidol can be recommended, which is also true to a somewhat lower extent for the antipsychotics olanzapine and aripiprazole. Treatment with lorazepam only should be avoided. This literature analysis reflects the positive clinical experience, especially when using haloperidol. To confirm these recommendations, further substantial clinical studies are needed.The English full-text version of this article can be found at SpringerLink (under "Supplemental").

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503785     DOI: 10.1007/s00482-013-1293-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  23 in total

1.  The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses.

Authors:  William Breitbart; Christopher Gibson; Annie Tremblay
Journal:  Psychosomatics       Date:  2002 May-Jun       Impact factor: 2.386

2.  Phenomenological subtypes of delirium in older persons: patterns, prevalence, and prognosis.

Authors:  Frances M Yang; Edward R Marcantonio; Sharon K Inouye; Dan K Kiely; James L Rudolph; Michael A Fearing; Richard N Jones
Journal:  Psychosomatics       Date:  2009 May-Jun       Impact factor: 2.386

Review 3.  [Methods and development of therapy recommendations for symptom control in palliative medicine].

Authors:  L Radbruch; B Alt-Epping; R Rolke; M Ujeyl; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

4.  A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis.

Authors:  David J Meagher; Maeve Leonard; Sinead Donnelly; Marion Conroy; Dimitrios Adamis; Paula T Trzepacz
Journal:  J Psychosom Res       Date:  2011-07-02       Impact factor: 3.006

Review 5.  Evidence-based treatment of delirium in patients with cancer.

Authors:  William Breitbart; Yesne Alici
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

Review 6.  The Confusion Assessment Method: a systematic review of current usage.

Authors:  Leslie A Wei; Michael A Fearing; Eliezer J Sternberg; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2008-04-01       Impact factor: 5.562

7.  Delirium. Pragmatic guidance for managing a common, confounding, and sometimes lethal condition.

Authors:  Steven C Samuels; Martin M Evers
Journal:  Geriatrics       Date:  2002-06

8.  An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients.

Authors:  William Breitbart; Annie Tremblay; Christopher Gibson
Journal:  Psychosomatics       Date:  2002 May-Jun       Impact factor: 2.386

9.  A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.

Authors:  W Breitbart; R Marotta; M M Platt; H Weisman; M Derevenco; C Grau; K Corbera; S Raymond; S Lund; P Jacobson
Journal:  Am J Psychiatry       Date:  1996-02       Impact factor: 18.112

Review 10.  Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review.

Authors:  Annmarie Hosie; Patricia M Davidson; Meera Agar; Christine R Sanderson; Jane Phillips
Journal:  Palliat Med       Date:  2012-09-17       Impact factor: 4.762

View more
  6 in total

1.  [QTc prolongation induced by intravenous sedation with Haloperidol, Prothipendyl and Lorazepam].

Authors:  Joachim Scharfetter; Peter Fischer
Journal:  Neuropsychiatr       Date:  2014-02-07

Review 2.  The pharmacologic management of delirium in children and adolescents.

Authors:  Susan Beckwitt Turkel; Alan Hanft
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

3.  [Delirium].

Authors:  K Singler; T Frühwald
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

Review 4.  Palliative Care of Adult Patients With Cancer.

Authors:  Claudia Bausewein; Steffen T Simon; Anne Pralong; Lukas Radbruch; Friedemann Nauck; Raymond Voltz
Journal:  Dtsch Arztebl Int       Date:  2015-12-11       Impact factor: 5.594

5.  Pharmacological interventions for delirium in intensive care patients: a protocol for an overview of reviews.

Authors:  Marija Barbateskovic; Laura Krone Larsen; Marie Oxenbøll-Collet; Janus Christian Jakobsen; Anders Perner; Jørn Wetterslev
Journal:  Syst Rev       Date:  2016-12-07

Review 6.  Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.

Authors:  Ailan Yu; Shanshan Wu; Zongwang Zhang; Tom Dening; Sai Zhao; Gillian Pinner; Jun Xia; Daogui Yang
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.